- Home
- ATNF vs XRTX Comparison
ATNF vs XRTX Comparison
Compare ATNF & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- XRTX
- Stock Information
- Founded
- ATNF 2016
- XRTX 2011
- Country
- ATNF United States
- XRTX Canada
- Employees
- ATNF N/A
- XRTX N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- XRTX Pharmaceuticals and Biotechnology
- Sector
- ATNF Health Care
- XRTX Health Care
- Exchange
- ATNF Nasdaq
- XRTX Nasdaq
- Market Cap
- ATNF 3.8M
- XRTX 4.2M
- IPO Year
- ATNF N/A
- XRTX N/A
- Fundamental
- Price
- ATNF $1.18
- XRTX $1.07
- Analyst Decision
- ATNF
- XRTX
- Analyst Count
- ATNF 0
- XRTX 0
- Target Price
- ATNF N/A
- XRTX N/A
- AVG Volume (30 Days)
- ATNF 234.0K
- XRTX 71.5K
- Earning Date
- ATNF 05-27-2025
- XRTX 05-27-2025
- Dividend Yield
- ATNF N/A
- XRTX N/A
- EPS Growth
- ATNF N/A
- XRTX N/A
- EPS
- ATNF N/A
- XRTX N/A
- Revenue
- ATNF N/A
- XRTX N/A
- Revenue This Year
- ATNF N/A
- XRTX N/A
- Revenue Next Year
- ATNF N/A
- XRTX N/A
- P/E Ratio
- ATNF N/A
- XRTX N/A
- Revenue Growth
- ATNF N/A
- XRTX N/A
- 52 Week Low
- ATNF $0.66
- XRTX $0.80
- 52 Week High
- ATNF $17.75
- XRTX $2.98
- Technical
- Relative Strength Index (RSI)
- ATNF 59.10
- XRTX 56.43
- Support Level
- ATNF $1.08
- XRTX $0.93
- Resistance Level
- ATNF $1.24
- XRTX $1.07
- Average True Range (ATR)
- ATNF 0.17
- XRTX 0.06
- MACD
- ATNF 0.02
- XRTX -0.00
- Stochastic Oscillator
- ATNF 54.90
- XRTX 72.92
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.